| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Slow Accounts Payable in Large Corporations Hurt Small Businesses |
|
Useful Advices - Slow Accounts Payable in Large Corporations Hurt Small Businesses
So many times you hear of small businesses working their rears off in order to satisfy lar According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ge corporate clients only to find them selves buried in bills due to those large corporati ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ns slow payments. Unfortunately this is a typical strategy to hoard cash. After all the sl lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ower they payout the more money they have in cash flow. It is not uncommon during downturn here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe in the economy for large companies to have outstanding invoices in excess of 120 days. T d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is is devastating for the small businessperson who is not anticipating on such slow paymen ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ts, but stringing out the payables now a days it seems is something all corporations do. I easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi is almost as bad as Sears in the 70s and 80s. If you sell to large retailers you have to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically eally watch your small business receivables as these corporate clients make you their own and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ private vendor bank. Now then let’s look at the new boss at Home Depot, from GE, savvy gu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi , watching numbers and look at their CFO; both sharks. Indeed this is great for sharehold ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rs equity, but devastating for the small manufacturers. If the small business cuts them of dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod f for slow pay, will they then do the same thing to another small business or will they bu cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin elsewhere? Will these large companies look to Sam Walton’s buy American First philosophie tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ? Or will they change with the times like the current corporate Wal-Mart? No, they are be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel holden to Wall Street to save a buck and if that buck is in China, tough. Great makes us ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ompetitive here, but we have a standard of living to protect, if we erode our job base and y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products therefore having a declining middle class we lose anyway. Home Depot loses their market a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nd we lose to China. There of course is much more to this issue, but this is one thing pe elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip haps if you run a small business that you have been thinking of? Consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:You're Fired! Tips for Avoiding the Termination Blues Medical Factoring: Business Financing for Medical Professionals Can Your Freight Bills be Factored?
|